Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administrationFrequency |
once weekly
|
| gptkbp:approvalYear |
2003
|
| gptkbp:ATCCode |
A16AB05
|
| gptkbp:CASNumber |
104143-89-1
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
gptkb:laronidase
|
| gptkbp:indication |
gptkb:Hurler-Scheie_syndrome
gptkb:Hurler_syndrome gptkb:Scheie_syndrome |
| gptkbp:KEGGID |
D03141
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi_Genzyme
gptkb:BioMarin_Pharmaceutical |
| gptkbp:mechanismOfAction |
gptkb:enzyme_replacement_therapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:product |
gptkb:recombinant_human_alpha-L-iduronidase
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201562
DB00095 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:RxCUI |
213022
|
| gptkbp:sideEffect |
fever
nausea vomiting headache allergic reaction rash |
| gptkbp:storage |
2-8°C
|
| gptkbp:UNII |
9I2K2V784M
|
| gptkbp:usedFor |
gptkb:Mucopolysaccharidosis_I
|
| gptkbp:bfsParent |
gptkb:Genzyme
gptkb:Genzyme_(2011) |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aldurazyme
|